Latest News

 Filter by Provider

Meta Platforms Inc. (NASDAQ:META) reports earnings tomorrow. Stock has soared 27% in past year but down 8% YTD. Technical indicators mixed, but ad strength may boost stock. Will track signals post-earnings.

The company also reported light sales, thanks to declining sales of key products like Eliquis and Ibrance.

American Tower reported first-quarter revenue of $2.56 billion, beating analyst estimates of $2.54 billion, according to estimates from Benzinga Pro. The company reported adjusted funds from operations (AFFO) of $2.75 per share, beating estimates of $2.58 per share.

Shift4 stock rose despite a Q1 earnings miss as other key metrics beat estimates.

Traders should be cautious, watching for volume increases and confirmation setups that could validate the unfolding of wave 3.

STRIDE INC was identified as a growth stock that isn't overvalued. NYSE:LRN is excelling in various growth indicators while maintaining a solid financial footing.

General Motors (NYSE: GM) recalls over 877,000 vehicles due to engine defects, amid ongoing NHTSA investigation.

Glass and electronic component manufacturer Corning (NYSE:GLW) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 16% year on year to $3.45 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.85 billion at the midpoint, or 5% above analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.4% above analysts’ consensus estimates.

As the U.S. and China continue to send mixed signals about the progress of their trade talks, economists at Morgan Stanley project that both nations will begin negotiations and slowly decrease tariffs on Chinese imports to 60% by the end of Q2.

Honeywell stock jumps earnings, outlook. The Dow Jones firm's planned separations are still expected next year.

The company reported a 2.3% year-over-year rise in its first-quarter revenue to $44.02 billion, exceeding an analyst estimate of $43.21 billion.

SolarBank Corp (NASDAQ: SUUN) plans to develop 7.2 MW DC solar project in NY, eligible for incentives and aiming for $0.0971/kWh compensation.

HR outsourcing provider Insperity (NYSE:NSP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.86 billion. Its non-GAAP profit of $1.57 per share was 22.4% below analysts’ consensus estimates.

Discover UNIVERSAL TECHNICAL INSTITUT, an undervalued growth gem. NYSE:UTI is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.

Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.

POTUS warns of vetoing any bill that cuts Social Security or federal health programs. GOP's tax plan may target Medicaid, setting up a key 2026 debate.

BTC/USD remains stable above $94,000 with a bullish pennant hinting at a breakout toward $99,000, fueled by rising institutional demand and optimistic forecasts.

Why the dividend investor may take a look at OSHKOSH CORP (NYSE:OSK).

Tobacco company Altria (NYSE:MO) announced better-than-expected revenue in Q1 CY2025, with sales up 11.5% year on year to $5.26 billion. Its non-GAAP profit of $1.23 per share was 3.5% above analysts’ consensus estimates.

Beeline Holdings, parent company of Beeline Loans, surpasses $1B in closed loans. CEO says reaching milestone shows strength and value in challenging market.

Trucking company PACCAR (NASDAQ:PCAR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 16% year on year to $6.91 billion. Its non-GAAP profit of $1.46 per share was 7.5% below analysts’ consensus estimates.

100 years ago, a can of Campbell's condensed tomato soup was advertised for $0.12.

Data backup provider Commvault (NASDAQ:CVLT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.2% year on year to $275 million. Guidance for next quarter’s revenue was better than expected at $268 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $1.03 per share was 11% above analysts’ consensus estimates.

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Rubrik, which recently named a new Chief Transformation Officer.

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.4% year on year to $169.2 million. The company’s full-year revenue guidance of $707.5 million at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.39 per share was 11.4% above analysts’ consensus estimates.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Hardware products and merchandising solutions provider Hillman (NASDAQ:HLMN) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.6% year on year to $359.3 million. On the other hand, the company’s full-year revenue guidance of $1.54 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was in line with analysts’ consensus estimates.

A fundamental analysis of (NASDAQ:ODFL): Why OLD DOMINION FREIGHT LINE (NASDAQ:ODFL) should be investigated by quality investors.

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the company’s full-year revenue guidance of $753 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.